Form 4: Elutia Inc. Director W. Matthew Zuga Acquires Stock Options

Director W. Matthew Zuga acquired 31,835 stock options in Elutia Inc. on June 6, 2024, under the company's Non-Employee Director Compensation Program.

Summary

• On June 6, 2024, W. Matthew Zuga, a director and 10% owner of Elutia Inc. (ELUT), was granted 31,835 stock options.
• The options were granted under the Issuer's Non-Employee Director Compensation Program.
• The exercise price of the options is $3.40.
• The options vest and become exercisable on the earlier of (i) the day immediately preceding the date of the Issuer's first annual meeting following the date of grant and (ii) the first anniversary of the date of grant, subject to continued service on the board.
• The expiration date for the options is June 5, 2034.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction related to director compensation, which is generally viewed neutrally to positively as it aligns interests. There are no indications of negative sentiment.

Positives

• The grant of stock options aligns the director's interests with those of the shareholders.
• The vesting schedule incentivizes continued service on the board.

Future Outlook

The document does not contain specific forward-looking statements beyond the vesting and expiration of the options.

Industry Context

Granting stock options to directors is a common practice to align their interests with those of the shareholders and incentivize long-term value creation. This is a standard component of director compensation packages in publicly traded companies.

Comparison to Industry Standards

• Director compensation packages often include a mix of cash, stock options, and restricted stock units.
• The specific terms of the option grant, such as the exercise price, vesting schedule, and expiration date, are generally aligned with industry practices and company-specific factors.
• Comparing Elutia's director compensation program to those of similar-sized companies in the medical technology sector would provide a more detailed benchmark.

Stakeholder Impact

• Shareholders may view the stock option grant as a positive sign, aligning the director's interests with the company's long-term success.
• The director benefits from the potential future appreciation of the company's stock.

Key Dates